Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Date of authorisation: 22/12/2025, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 November 2026 - 14:45

Human medicines European public assessment report (EPAR): Wayrilz, rilzabrutinib, Date of authorisation: 22/12/2025, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/wayrilz

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters